Desh Rakshak Aushdhalaya Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 351394,
    "name": "Desh Rakshak",
    "stock_name": "Desh Rakshak",
    "full_name": "Desh Rakshak Aushdhalaya Ltd",
    "name_url": "stocks-analysis/desh-rakshak",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.90",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "26.90",
    "mcapval": "15.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531521,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE971E01016",
    "curr_date": "Sep 25, 03:30 PM",
    "curr_time": "17:36 PM",
    "last_traded_at": "Sep 25, 03:30 PM IST",
    "bse_nse_vol": "100 ",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-4178353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/DeshRakshakAush_valuationdot_4178353.png",
        "date": "2026-09-02 08:00:28",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a stagnant share price at ₹26.90 and a challenging sector environment, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for value investors seeking opportunities in an otherwise expensive peer group."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-reports-sharp-decline-in-quarterly-financial-performance-amid-sector-challenges-4152521",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DeshRakshakAush_fintrenddot_4152521.png",
        "date": "2026-08-14 08:00:19",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked deterioration in its financial performance during the quarter ended June 2026. The company’s financial trend has shifted from flat to negative, reflecting significant challenges in revenue growth, profitability, and operational efficiency compared to its historical performance and broader market benchmarks."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-4136701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DeshRakshakAush_valuationdot_4136701.png",
        "date": "2026-08-05 08:00:57",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an attractive rating. Despite a challenging price performance over the past year, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more favourable entry point relative to its historical and peer benchmarks."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-ltd-valuation-shifts-signal-renewed-price-attractiveness-4104296",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/DeshRakshakAush_valuationdot_4104296.png",
        "date": "2026-07-16 08:00:14",
        "description": "Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling case relative to its historical averages and peer group, prompting a reassessment of its price attractiveness amid ongoing sector volatility."
      }
    ],
    "total": 230,
    "sid": "351394",
    "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Sep-2026",
      "details": "Intimation for publication of public notice of 45th Annual General Meeting of the Company pursuant to Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Sep-2026",
      "details": "Intimation for publication of public notice of 45th Annual General Meeting of the Company under Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Regulations) 2015",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (SEBI) (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "01-Sep-2026",
      "details": "Intimation regarding letter providing weblink where Annual Report for the financial year 2025-2026 and Notice of the 45th Annual General Meeting can be accessed on Companies website under Regulation 30 of the SEBI (Listing Obligations and Disclosure Regulations) 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-09-02 08:00:28

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a significant shift in its valuation parameters, moving from a risky to a very attractive valuation grade. Despite a stagnant share price at ₹26.90 and a challenging sector environment, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a compelling case for value investors seeking opportunities in an otherwise expensive peer group.

Read full news article

Desh Rakshak Aushdhalaya Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Sector Challenges

2026-08-14 08:00:19

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a marked deterioration in its financial performance during the quarter ended June 2026. The company’s financial trend has shifted from flat to negative, reflecting significant challenges in revenue growth, profitability, and operational efficiency compared to its historical performance and broader market benchmarks.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-05 08:00:57

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an attractive rating. Despite a challenging price performance over the past year, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more favourable entry point relative to its historical and peer benchmarks.

Read full news article

Desh Rakshak Aushdhalaya Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-16 08:00:14

Desh Rakshak Aushdhalaya Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade. Despite recent share price declines, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling case relative to its historical averages and peer group, prompting a reassessment of its price attractiveness amid ongoing sector volatility.

Read full news article

View All News